Bottom line
What is FSTAX's expense ratio?
FSTAX's expense ratio is 0.93%, or about $93 a year on every $10,000 invested. That is more expensive than 67% of core / intermediate bond funds we track (median 0.71%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 24, 2026
FSTAX fee table
| Net expense ratio | 0.93% |
|---|---|
| Gross expense ratio | 0.93% |
| Management fee | 0.68% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 24, 2026
What FSTAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| FSTAX | $491 | $685 | $894 | $1,497 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.93% expense ratio costs roughly $51,800 in lost growth, versus about $40,300 for the median core / intermediate bond fund (0.71%).